Acute insulin responses to glucose and arginine as predictors of β-cell secretory capacity in human islet transplantation

Transplantation

Volumn 84, Issue 10, 2007, Pages 1357-1360

  Rickels, Michael R ^a   Naji, Ali ^a   Teff, Karen L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cell function; Insulin secretion; Islet graft function

Indexed keywords

ARGININE; GLUCOSE; INSULIN;

ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; GRAFT RECIPIENT; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESPONSE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; DRUG EFFECT; GLUCOSE CLAMP TECHNIQUE; PHYSIOLOGY; SECRETION;

ARGININE; DIABETES MELLITUS, TYPE 1; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION;

EID: 38449086260     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000287595.16442.a7     Document Type: Article

References (19)

1. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148.
2. Rickels MR, Schutta MH, Markmann JF, et al. Beta-cell function following human islet transplantation for type 1 diabetes. Diabetes 2005; 54: 100.
3. Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004; 53: 955.
4. Rickels MR, Schutta MH, Mueller R, et al. Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes 2005; 54: 3205.
5. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
6. Shapiro AMJ, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
7. Teuscher AU, Kendall DM, Smets YF, et al. Successful islet autotransplantation in humans: Functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998; 47: 324.
8. Eich T, Eriksson O, Lundgren T. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 2007; 356: 2754.
9. Robertson RP. AIRarg and AIRgluc as predictors of insulin secretory reserve. Transpl Proc 2004; 36: 1040.
10. Robertson RP. Consequences on beta-cell function and reserve after long-term pancreas transplantation. Diabetes 2004; 53: 633.
11. Markmann JF, Deng S, Huang X, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003; 237: 741.
12. Rickels MR, Naji A, Teff KL. Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. J Clin Endocrinol Metab 2006; 91: 2138.
13. Ward WK, Halter JB, Beard JC, Porte D, Jr. Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol 1984; 246: E405.
14. Seaquist ER, Robertson RP. Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 1992; 89: 1761.
15. Teuscher AU, Seaquist ER, Robertson RP. Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients. Diabetes 1994; 43: 593.
16. Ganda OP, Srikanta S, Brink SJ, et al. Differential sensitivity to beta-cell secretagogues in early, type-I diabetes-mellitus. Diabetes 1984; 33: 516.
17. Rickels MR, Kamoun M, Kearns J, et al. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. J Clin Endocrinol Metab 2007; 92: 2410.
18. The Worcester Human Islet Transplantation Group. Autoimmunity after islet-cell allotransplantation [letter]. N Engl J Med 2006; 355: 1397.
19. Desai NM, Goss JA, Deng S, et al. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: Local immunosuppression or islet toxicity? Transplantation 2003; 76: 1623.